| NCT ID | NCT07601022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jin Joo Park |
| Condition | Acute Heart Failure (AHF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-05-08 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-05-08 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.
Eligibility Criteria
Inclusion Criteria: * Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure * NT-proBNP ≥300 pg/mL * Patients who underwent electrocardiography at least once Exclusion Criteria: * History of congenital heart disease * Patients with a dominant electronic pacemaker rhythm * Patients with a heart rate \>140 beats per minute or electrocardiograms with excessive noise
Frequently Asked Questions
Who can join the NCT07601022 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Acute Heart Failure (AHF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07601022 currently recruiting?
Yes, NCT07601022 is actively recruiting participants. Visit ClinicalTrials.gov or contact Jin Joo Park to inquire about joining.
Where is the NCT07601022 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT07601022 clinical trial?
NCT07601022 is sponsored by Jin Joo Park. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.